Feeds

Dissolving the plastic bag problem

The Phage Factor

  • alert
  • submit to reddit

Bridging the IT gap between rising business demands and ageing tools

In 1919 d'Herelle isolated "phages", agents which were fatal to bacteria, and used them successfully to treat typhus in chickens, and dysentry in people. In 1939 electron microscopy confirmed them to be viruses.

Phage therapies began to be developed, but fell from favour in the West after the commercialization of antibiotics in the 1940s. But they are still used extensively in the countries of the former USSR and in eastern Europe.

d'Herelle had been invited in 1936 to co-found the Tbilisi Institute, Georgia (now the Georg Eliava Institute), and though he was associated with it only briefly it subsequently became the main world research and development centre for phage therapies. These have been applied to treating a large number of -itises (inflamations) and skin conditions, including chronic ones, and in post-operative care.

Phages have their attractions compared to antibiotics. The success rates are claimed to be comparable. As anti-microbial weapons, they are precision bombers, in comparison to antibiotics which tend to nuke everything. They have few if any side effects, and need only small doses to work. R&D is crucially not capital or IT intensive - the Tbilisi Institute would send for samples of river water to be hauled up in jars. With increasing antibiotic resistance stemming from their widespread use now beginning to cause problems, phage therapy is seen by proponents as an option.

Yet here, in drawing a parallel with Daniel Burd's ambition to see his discovery in large-scale use, the story of phage therapy gives pause for thought. Despite access now to decades of research, in the West funding for phage research continues to be scant. Potential investors have to square up to the gorilla that is intellectual and property rights in the legal/patents ring.

In addition regulators such as the FDA maintain that each and every phage of a therapeutic combination must separately pass scrutiny. But they clearly recognize that prescribing physicans have resorted to combination antibiotics at their discretion, and that administering a herbal remedy, regardless of efficacy, necessarily entails taking a cocktail of pharmacologically active ingredients. (Not to mention GM foods).

We note Daniel is an accomplished pianist with an interest in jazz improvisation, and hope that the comparison with Felix d'Herelle does not dissuade him from pursuing a scientific career. But if science's loss were to become music's gain then in 10 years time it may become clear that a different analogy should have been drawn here, one perhaps with Keith Jarrett.

So why haven't we heard of Daniel Burd?

Science and the consensus

The breakthrough first aired in the May 22, 2008 edition of the Ontario Record (audited circulation 6 months to March 31, 2006 of 73,852). It never made the BBC, which instead on June 1 chose to lead with the ban on thin plastic bags in China, a story it had covered in early January, when the People's Republic announced its intentions. A search of the online presence of the UK's national dailies for Daniel Burd also draws blanks.

Perhaps it is because Burd is not a tenured professor, and is not supported by a long list of citations and a vociferous "consensus". Indeed, he does not even have a graduate degree. He is only 16. On the other hand he has the imprimatur of science. One suspects the BBC of 2008 of being unable to pass up opportunity to broadcast to its home audience the message that it is too dilatory over saving the planet. ®

Mobile application security vulnerability report

More from The Register

next story
Malaysian Airlines flight MH17 claimed lives of HIV/AIDS cure scientists
Researchers, advocates, health workers among those on shot-down plane
Mwa-ha-ha-ha! Eccentric billionaire Musk gets his PRIVATE SPACEPORT
In the Lone Star State, perhaps appropriately enough
All those new '5G standards'? Here's the science they rely on
Radio professor tells us how wireless will get faster in the real world
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
Diary note: Pluto's close-up is a year from … now!
New Horizons is less than a year from the dwarf planet
Boffins discuss AI space program at hush-hush IARPA confab
IBM, MIT, plenty of others invited to fill Uncle Sam's spy toolchest, but where's Google?
prev story

Whitepapers

Designing a Defense for Mobile Applications
Learn about the various considerations for defending mobile applications - from the application architecture itself to the myriad testing technologies.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Reducing security risks from open source software
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
Boost IT visibility and business value
How building a great service catalog relieves pressure points and demonstrates the value of IT service management.
Consolidation: the foundation for IT and business transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.